COR vs CVS: fair value comparison
Cencora, Inc. and CVS Health Corporation · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our ranking by discount to fair value.
| COR | CVS | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $323.85 | $86.16 |
| 12-month range | $252.74–$374.75 | $70.08–$110.60 |
| Rank by discount to fair value | #58 of 108 Healthcare | #59 of 108 Healthcare |
| Quality grade | F | F |
| Leverage | High | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Overbought | Neutral |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: COR fair value analysis · CVS fair value analysis